WDSC Americas – Boston – November 2025

AB Cube was an exhibitor at the World Drug Safety Congress Americas, held November 4–6 at the Boston Convention & Exhibition Center. 

This year’s event—Innovation, Technology and Performance for Drug Safety Professionals—focused on responsible, human-augmented AI, real-world evidence, advanced therapies, and compliance readiness. 

Highlights included practical sessions on operationalizing AI across the safety value chain, data governance, and regulatory validation. At our booth, we demonstrated how SafetyEasy® Vigilance addresses these priorities—automating case intake and signal detection, reinforcing data integrity, and enabling proactive risk management. 

The congress underscored that augmented intelligence, not just automation, is the new standard in pharmacovigilance—a mission AB Cube is fully committed to.